If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    3.00 (0.52%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.55m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Trading Update

11 Nov 2024 07:00

RNS Number : 5909L
Science Group PLC
11 November 2024
 

 

11 November 2024

 

Science Group plc

(the "Company" or "Science Group")

 

Trading Update

 

 

The Group's trading performance for FY24 remains on track to deliver another record year of adjusted operating profit in line with expectations.

 

While not immune to the UK and international political/economic environment, Science Group benefits from the resilience inherent in its portfolio. In that regard, the UK budget on 30 October 2024 increased Employer's National Insurance with an estimated annualised increase to the Group's operating cost base in the order of £0.7 million. The Board will consider how to mitigate this impact during the forthcoming 2025 planning cycle.

 

Science Group retains a very strong balance sheet with significant cash resources. At 31 October 2024, the Group had gross cash of £37.7 million and net funds of £25.6 million, after returning a total of £7.4 million to shareholders in 2024 through the buyback programme and an increased dividend. As announced on 22 October 2024, the operation of the share buyback programme is now delegated to Panmure Liberum.

 

The Group's Term Loan expires in September 2026. In addition, the Group has an undrawn Revolving Credit Facility ("RCF") of £25 million which is available until December 2026. In order to support the Group's corporate strategy, the Board is considering:

 

· Refinancing the Term Loan for a new 10 year period, secured on the Group's freehold properties, and

· Renewing the RCF on a new 5 year term and increasing the facility to £30 million with an additional £10 million accordion option.

 

Negotiations are progressing well and term sheets have been agreed. Legal documentation is anticipated to take several weeks. If concluded on satisfactory terms, these new, increased facilities with extended commitment periods, combined with the Group's existing cash resources, would strengthen Science Group's ability to continue to consider corporate opportunities which may arise.

 

 

- Ends -

 

 

For further information:

Science Group plc

Martyn Ratcliffe, Executive Chair

Tel: +44 (0) 1223 875 200

Jon Brett, Finance Director

www.sciencegroup.com  

Cannacord Genuity Limited (Nominated Adviser and Joint Broker)

Simon Bridges, Andrew Potts

Tel: +44 (0) 20 7523 8000

Panmure Liberum Capital Limited (Joint Broker)

Max Jones, John More

Tel: +44 (0) 20 3100 2000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUWANRSVUARAA
Date   Source Headline
9th Apr 20217:00 amRNSPosting of AGM documents & Notice of AGM
22nd Mar 20217:00 amRNSIssue of share options and PDMR dealing
9th Mar 20217:00 amRNSAudited results for year ended 31 December 2020
4th Mar 20215:00 pmRNSTR1: Notification of Major Interest in Shares
11th Jan 20217:00 amRNSTrading, Business and Board Update
8th Jan 20214:40 pmRNSTR1: Notification of Major Interest in Shares
2nd Dec 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSTransaction in Own Shares
23rd Nov 20207:00 amRNSTransaction in Own Shares
20th Nov 20207:00 amRNSTransaction in Own Shares
18th Nov 20205:00 pmRNSTR1: Notification of Major Interest in Shares
16th Nov 202010:46 amRNSTransaction in Own Shares
16th Nov 202010:45 amRNSTransaction in Own Shares
16th Nov 20207:00 amRNSTransaction in Own Shares
13th Nov 20207:00 amRNSTransaction in Own Shares
11th Nov 20207:00 amRNSPDMR dealing
12th Oct 20207:00 amRNSTrading Update
8th Oct 20207:00 amRNSIssue of share options & PDMR dealing
5th Oct 20207:00 amRNSTR1: Notification of Major Interest in Shares
1st Oct 202011:15 amRNSTR1: Notification of Major Interest in Shares
30th Sep 20202:30 pmRNSDirector Dealing & Exercise of Share Options
30th Sep 20201:30 pmRNSProposed Director Dealing
10th Sep 20207:00 amRNSTrading and Dividend Update
28th Jul 20207:00 amRNSInterim Results for six month period ended 30/6/20
17th Jun 20207:01 amRNSBoard Appointment
17th Jun 20207:00 amRNSNominated Adviser and Joint Broker
16th Jun 202012:15 pmRNSResult of Annual General Meeting
16th Jun 20207:00 amRNSAGM Trading Update
9th Jun 20207:01 amRNSTR1: Notification of Major Interest in Shares
9th Jun 20207:00 amRNSTransaction in Own Shares
8th Jun 20207:00 amRNSTransaction in Own Shares
5th Jun 20207:00 amRNSTransaction in Own Shares
4th Jun 20207:00 amRNSTransaction in Own Shares
29th May 20207:00 amRNSTop Up of Bank Loan
22nd May 20207:00 amRNSTransaction in Own Shares
18th May 20207:00 amRNSTransaction in Own Shares
15th May 20207:00 amRNSPosting of AGM documents and Director Changes
11th May 20207:00 amRNSAGM Update, Capital Allocation and Dividend Policy
7th May 20204:50 pmRNSChange of auditors
7th May 20207:00 amRNSTransaction in Own Shares
6th May 20207:00 amRNSTransaction in Own Shares
4th May 20207:00 amRNSVentilator Programme, Trading & Financial Update
2nd Apr 20204:00 pmRNSTR1: Notification of Major Interest in Shares
2nd Apr 20201:30 pmRNSTR1: Notification of Major Interest in Shares
31st Mar 20201:46 pmRNSTrading Update, AGM and Covid-19
31st Mar 20201:45 pmRNSUK Government Ventilator Programme
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSAudited results for year ended 31 December 2019
6th Jan 20207:00 amRNSAppointment of Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.